BOLERO-4: A Phase 2, Open-Label, Multicenter, Single-Arm Trial Investigating The Efficacy And Safety Of First-Line Everolimus (Eve) In Combination With Letrozole (Let) In Postmenopausal Patients (Pts) With Estrogen Receptorpositive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Metastatic Or Locally Advanced Unresectable Breast Cancer (Bc)

AuthID
P-00J-XV4
10
Author(s)
Bachelot, T
·
Villanueva, C
·
Cruz, FM
·
Hegg, R
·
Brechenmacher, T
·
Manlius, C
·
Ringeisen, F
·
Cardoso, F
Tipo de Documento
Abstract
Year published
2015
Publicado
in BREAST, ISSN: 0960-9776
Volume: 24, Páginas: S41-S41 (1)
Indexing
Publication Identifiers
Wos: WOS:000365078900056
Source Identifiers
ISSN: 0960-9776
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.